期刊文献+

Sprouty2与肿瘤的研究进展 被引量:1

Investigation Progression of Sprouty2 and Tumors
下载PDF
导出
摘要 Sprouty2蛋白对受体酪氨酸激酶(RTK)等信号通路起着重要的抑制作用,其表达在多种肿瘤组织中发生明显下降,并可进一步引起细胞异常增殖、转化及新生血管形成,从而促进肿瘤的发生及发展。现就其与肿瘤发生及发展关系的研究进展进行综述。 The Sprouty2 protein can inhibit many signaling pathways, such as receptor tyrosine kinase (RTK). It is down-regulated in tumors ,which is often associated with abnormal cell proliferation, transformation and neovascularization, to stimulate the initiation and progression of tumors. This article reviewed the newest progression of sprouty2 protein and tumors.
出处 《医学综述》 2008年第18期2772-2773,共2页 Medical Recapitulate
关键词 Sprouty2蛋白 信号通路 肿瘤 Sprouty2 protein Signaling pathways Tumor
  • 相关文献

参考文献17

  • 1Hacohen N, Kramer S, Sutherland D, et al. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways [ J ]. Cell, 1998,92 ( 2 ) : 253 -263.
  • 2Guy GR,Wong ES, Yusoff P, et al. Sprouty: how does the branch manager work? [ J ]. J Cell Sci,2003,116 ( Pt 15 ) :3061-3068.
  • 3Tefft D, Lee M, Smith S, et al. mSprouty2 inhibits FGFlO-activated MAP kinase by differentially binding to upstream target proteins [J ]. Am J Physiol Lung Cell Mol Physiol, 2002, 283 (4): 700-706.
  • 4Lim J, Yusoff P, Wong ES, et al. The cysteine-rich sprouty translocation domain targets mitogen-activated protein kinase inhibitory proteins to phosphatidylinositol 4,5-bisphosphate in plasma membranes [ J ]. Mol Cell Biol,2002,22 (22) :7953-7966.
  • 5Lao DH, Chandramouli S, Yusoff P, et al. A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibmblast growth factor receptor stimulation [ J ]. J Biol Chem, 2006, 281 ( 40 ) : 29993 -30000.
  • 6Fong CW, Chua MS, McKie AB, et al. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma [ J ]. Cancer Res,2006,66 ( 4 ) :2048-2058.
  • 7Kwabi-Addo B, Ozen M, htmann M. The role of fibroblast growth factors and their receptors in prostate cancer [ J ]. Endocr Relat Cancer,2004,11 ( 4 ) :709-724.
  • 8Martinez N, Garcia-Dominguez CA, Domingo B, et al. Spmuty2 binds Grb2 at two different praline-rich regions, and the mechanism of ERK inhibition is independent of this interaction [ J ]. Cell Signal,2007,19 ( 11 ) :2277-2285.
  • 9Burgess WH, Dionne CA, Kaplow J, et al. Characterization and cD- NA cloning of phospholipase C-gamma,a major substrate for heparin-binding growth factor 1 ( acidic fibroblast growth factor) -activated tyrosine kinase [ J ]. Mol Cell Biol, 1990,10 (9) :4770-4477.
  • 10Mohammadi M,Honegger AM, Rotin D, et al. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Fig) is a binding site for the SH2 domain of phospholipase C-gamma 1 [ J ]. Mol Cell Biol, 1991,11 ( 10 ) :5068-5078.

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部